Company intelligence / Profile preview

M.A.G.I.C. Clinic

Calgary, Alberta, Canadamagiccalgary.ca ↗

Ownership: Private
Development stage: Phase 1

Overview

The clinic is the largest in Alberta for patients with lysosomal diseases needing enzyme or spinal injection therapies. It offers rapid access to advanced genetic sequencing technologies and participates in multiple clinical trials for rare metabolic/genetic disorders.

Therapeutic areas: Metabolic DisordersOncologyRare Diseases
Modalities: Enzyme replacement therapies (ERT)Gene therapyPharmacogenomics/genetic testingNon-invasive prenatal screening
Industry: Academic Hospital/University/Research

Drug pipeline

1 asset

ABX1100

Phase 1

Indications: Late-onset Pompe disease

Partnerships

Collaborates with major biopharma companies including BioMarin, Sanofi, Alexion for clinical research/trials involving their investigational drugs or registries.

Beyond the preview

Go deeper on M.A.G.I.C. Clinic.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M.A.G.I.C. Clinic.

Explore the full profile